The First Patient Treated with BRL Medicine’s BRL-201 Therapy Achieves Over 5 Years of Cancer-Free Survival
2025-09-17
BRL Medicine Awarded "First Prize of 2024 Shanghai Science and Technology Progress Award"
2025-08-26
World's first β0/β0 severe thalassemia patient cured for 5 years by BRL-101
2025-08-20
EHA 2025 | BRL Medicine Delivers Oral Presentation on Latest Clinical Progress of BRL-101 Therapy for TDT and SCD
2025-06-18
BRL Medicine Non viral Targeted Integration PD1-CAR-T Therapy for Lupus Erythematosus Approved by China IND
2024-11-05
Molecular Cell article! BRL Medicine has developed a new gene editing tool with high activity and smaller size
2024-08-02
